// company-profile

KalVista Pharmaceuticals, Inc. Insider Trading

KALV

Every SEC Form 4 insider trading filing for KalVista Pharmaceuticals, Inc. (KALV) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings183Insiders23
// api This KalVista Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=KALV" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, KalVista Pharmaceuticals, Inc. insiders sold $0 across 50 transactions with no open-market purchases.

  • Most active insider: Palleiko Benjamin L with 18 transactions totaling $0.

Activity skews bearish — sales outpace buys.

Institutional Ownership

Top 13F-HR holders of KalVista Pharmaceuticals, Inc. as of 2026-06-30

— stable
Total reported AUM
$189
QoQ change
Reporting period
2026-06-30
#1
IFP Advisors, Inc
CIK 1641866
$189
7 shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 11, 2026Unkart Edward WKALV
Disposition
10,000
Jun 11, 2026Unkart Edward WKALV
Disposition
7,000
Jun 11, 2026Palleiko Benjamin LKALV
Disposition
304,688
Jun 11, 2026Unkart Edward WKALV
Disposition
6,000
Jun 11, 2026Unkart Edward WKALV
Disposition
12,000

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →